News & Announcements
Assistant Dean at Temple University School of Medicine Selected One of Region's Most Influential Latinos
Raul A. DeLa Cadena, MD, Assistant Dean and Director of the Recruitment, Admissions and Retention (RAR) Program at Temple University School of Medicine, has been selected as one of the "Delaware Valley's Most Influential Latinos" for 2012. He was selected for the honor by the Most Influential Latinos Foundation, whose stated mission is to support and encourage Latino leadership and empowerment. Dr. DeLa Cadena will be recognized, along with the other honorees, at a Gala Dinner and celebration on November 29 in Philadelphia.
"This is a great honor for which I am pleased to be recognized," said Dr. DeLa Cadena. "It is also a reflection on Temple University School of Medicine's proud legacy of helping disadvantaged students overcome academic and economic obstacles that contribute to their underrepresentation among our nation's physicians."
As Director of Temple's RAR Program, Dr. DeLa Cadena works to enhance the recruitment of underrepresented minorities to the School of Medicine. The primary purpose of the RAR Program is to help Temple identify, enroll, retain and graduate physicians from such backgrounds to infuse diversity into the healthcare workforce in the profession of medicine both regionally and nationally.
"This selection of Dr. DeLa Cadena as one of the region's most influential Latinos is well deserved," said Arthur M. Feldman, MD, PhD, Executive Dean of Temple University School of Medicine. "Dr. DeLa Cadena works tirelessly to help Temple actualize its commitment to diversity in its student body, while also maintaining excellence in its academic programs."
Dr. DeLa Cadena also serves as Professor of Physiology and holds a faculty appointment at Temple's Sol Sherry Thrombosis Research Center. His research focuses on the pathophysiology of Diabetic Retinopathy and Rheumatoid Arthritis.
Date Published: Wednesday, November 21, 2012
back | view all news
Common Antidepressant May Hold the Key to Heart Failure Reversal
A team led by researchers at Temple University School of Medicine found that a commonly prescribed antidepressant restored heart function in mice with heart failure, a finding that could lead to clinical trials for a disease long considered irreversible.
read more »
Nirag Jhala, MD, Appointed Director of Anatomic Pathology and Director of Cytopathology at Temple University Hospital
Nirag C. Jhala, MD, has been appointed Director of Anatomic Pathology & Director of Cytopathology at Temple University Hospital, and Professor of Pathology and Laboratory Medicine at Temple University School of Medicine.
read more »
Temple Researchers Receive $7.4 Million Grant to Explore Brain Impairment in HIV-1 Patients
Research will examine how HIV-1 and cocaine interaction worsens brain function.
read more »